Nothing but negotiation

The Gap Partnership

Mylan acquires two dermatological products from Valeant

Mylan has completed the acquisition of two dermatological treatments from Valeant Pharmaceuticals.

06 February 2012

Mylan might have recently used a negotiation consultancy, as the drugs company has completed the acquisition from Valeant Pharmaceuticals of two dermatological products.

It has secured a licence to market and manufacture Fluorouracil 5 per cent USP cream, which is used for solar or multiple actinic keratosis, as well as for superficial basal cell carcinomas when more conventional tools have been deemed impractical.

Furthermore, it has acquired the abbreviated new drug application for Benzoyl Peroxide Gel / Clindamycin Phosphate, which is utilised to treat acne vulgaris and had sales of around $205 million (£129.61 million) during 2011.

"The acquisition of these two products reflects Mylan's continued strategy of creating value through increasing our position in key therapeutic areas and dosage forms, such as dermatological topicals," chief executive officer of the company Heather Bresch said.

Valeant Pharmaceuticals specialises in the development, advertisement and manufacture of drugs, specifically within the areas of branded generics, neurology and dermatology.

Posted by Ron Maverick

Source: Mylan press release, February 6th

Gap News

March 2014

The Negotiation Roadshow 2014

Generating value through creative negotiation

Read more

July 2013

Trading Global: Negotiating in the Far East

The Gap Partnership are hosting a complimentary Lunch & Learn seminar in association with UK Trade & Investment

Read more

April 2013

GroceryAid Negotiation Event Raises £26,550

The Gap Partnership, in conjunction with Asda, SC Johnson and Waitrose, host one-day negotiation workshop

Read more

February 2013

Trading Global - Negotiating in the Far East

What is the impact of cultural differences on your negotiations?

Read more

December 2012

The Gap Partnership Release New Negotiation Video

The Nothing but Negotiation video series continues with collaborative negotiation

Read more